India  

Stigma attached to COVID-19 stopping many people from coming forward to get tested and treated: AIIMS Director

DNA Thursday, 23 April 2020
AIIMS Director Prof Randeep Guleria said the tendency to not come forward due to stigma is leading not only to huge mental agonies and problems but also higher morbidity and mortality.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Randeep Guleria Randeep Guleria Indian pulmonologist

India's growth in COVID cases not as high as other countries: AIIMS Director [Video]

India's growth in COVID cases not as high as other countries: AIIMS Director

All India Institute of Medical Sciences Director Randeep Guleria on June 27 reacted on surging COVID-19 cases in the country. He said that the rise in COVID cases in country are not that high if compared to countries affected from the invisible enemy and India has low mortality rate. He said, "Rise in cases in India is still not as high as compared to other countries. In US, there've been almost 40,000 cases per day in last 2 days, our numbers aren't that high. Cases per million population continue to be low and we still have low mortality rate."

Credit: ANI    Duration: 01:37Published
India has very low COVID-19 cases for per million population: AIIMS Director [Video]

India has very low COVID-19 cases for per million population: AIIMS Director

The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria said on June 12 that India is still very low in terms of number of cases of coronavirus, if one looks at number of cases per million population. "Although India has gone up to the 4th rank as far as COVID-19 cases are concerned, we have to accept that it is because of the population we have. If we look at number of cases per million population, we still are very low in terms of number of cases," said Dr Randeep Guleria.

Credit: ANI    Duration: 01:13Published
Delhi may not see 5.5 lakh corona cases by July 31, but we need to be ready: AIIMS Director [Video]

Delhi may not see 5.5 lakh corona cases by July 31, but we need to be ready: AIIMS Director

The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria reacted over Delhi's Deputy Chief Minister Manish Sisodia's statement that 5.5 lakh cases are expected in the national capita by July 31. "Number of cases in Delhi may not be as high as predicted but still whatever be the number, we have to increase our capacity so that we can manage increasing load that healthcare system is going to get," he said.

Credit: ANI    Duration: 01:09Published
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug [Video]

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe COVID-19 patients because of multiple drugs being used. Being asked about his opinion on WHO 'temporarily' suspending clinical trials of HCQ for COVID-19, Dr Guleria said, "There are 2 different aspects, using Hydroxychloroquine as part of treatment for severe COVID-19 patients has higher chance that you may have toxicity because of multiple drugs being used. And there are certain drugs which along with hydroxychloroquine can increase the chance of cardiac toxicity. On the other hand, when we are giving it as prophylaxis or in mild illness and giving it alone the chances of side effects are much less. We, as physicians have been using hydroxychloroquine for almost 30-40 years. Patients have been using it daily, not for week but for months and years with no side effects. So, when it is used judiciously, appropriately and not in combination with other drugs where the side effects can become much more, there is good suggestive data that suggests it is useful."

Credit: ANI    Duration: 01:26Published

All India Institute of Medical Sciences, New Delhi All India Institute of Medical Sciences, New Delhi Medical School,Hospital and Public Medical Research University based in New Delhi,India

COVID-19 cured CAPF personnel donate plasma for treatment [Video]

COVID-19 cured CAPF personnel donate plasma for treatment

Central Armed Police Forces (CAPF) personnel who have recovered from coronavirus, donated plasma for treatment of COVID-19 positive patients. Speaking on it, Commandant 31st Battalion of CRPF, Deependra Rajput said, "139 CRPF jawans had tested positive for COVID-19 here. Out of 139, 138 have fully recovered and have returned to duty. Till now, three jawans have donated plasma and more are willing to do so. This is another way to serve the country." DIG of BSF, Lalit Kumar said, "We are preparing list of those who have recovered from COVID-19 and the list is with AIIMS hospital so whenever they'll feel need of plasma of BSF personnel, we will donate it to them."

Credit: ANI    Duration: 01:43Published

Tweets about this